Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

European Committee on Antimicrobial Susceptibility Testing (EUCAST) Technical Notes on antimicrobial susceptibility

G Kahlmeter1, D F J Brown, F W Goldstein

  • 1Klinisk mikrobiologi, Växjö, Sweden. gunnar.kahlmeter@ltkronoberg.se

Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
|May 17, 2006
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Exploring the opportunity for therapeutic drug monitoring (TDM) and precision dose antimicrobials in an outpatient antimicrobial therapy (OPAT) service: a prospective observational study.

The Journal of antimicrobial chemotherapy·2026
Same author

Pharmacodynamics of taniborbactam in combination with cefepime studied in an in vitro model of infection.

International journal of antimicrobial agents·2024
Same author

Time course of ischemic and bleeding burden in consecutive patients undergoing transcatheter aortic valve replacement (FOCUS-ONE Registry).

International journal of cardiology·2023
Same author

Comment on: The case for 'conservative pharmacotherapy'.

The Journal of antimicrobial chemotherapy·2021
Same author

The pharmacodynamics of minocycline alone and in combination with rifampicin against Staphylococcus aureus studied in an in vitro pharmacokinetic model of infection.

The Journal of antimicrobial chemotherapy·2021
Same author

In vitro pharmacodynamics of omadacycline against Escherichia coli and Acinetobacter baumannii.

The Journal of antimicrobial chemotherapy·2020

The European Committee on Antimicrobial Susceptibility Testing (EUCAST) harmonizes antimicrobial susceptibility testing breakpoints in Europe. Technical Notes will highlight the rationale behind EUCAST

Area of Science:

  • Microbiology
  • Pharmacology
  • Clinical Medicine

Background:

  • Antimicrobial resistance necessitates standardized susceptibility testing.
  • Harmonized breakpoints ensure consistent interpretation of antimicrobial efficacy across Europe.
  • The European Committee on Antimicrobial Susceptibility Testing (EUCAST) plays a key role in this standardization.

Purpose of the Study:

  • To outline the objectives of EUCAST in harmonizing antimicrobial breakpoints.
  • To establish EUCAST as the breakpoint committee for the European Medicines Agency (EMEA).
  • To introduce a series of Technical Notes detailing the rationale behind EUCAST breakpoint decisions.

Main Methods:

  • Harmonization of breakpoints for antimicrobial agents across European laboratories.

Related Experiment Videos

  • Acting as the breakpoint committee for the European Medicines Agency (EMEA) during new drug registration.
  • Publication of detailed procedures and rationale documents on the EUCAST website and in CMI.

    • Main Results:

    • Established procedures for harmonizing and setting antimicrobial breakpoints are available.
    • EUCAST serves as the official breakpoint committee for EMEA.
    • A new series of Technical Notes will be published to explain the basis for EUCAST decisions.

    Conclusions:

    • EUCAST is central to standardizing antimicrobial susceptibility testing in Europe.
    • Transparency in breakpoint setting is enhanced through the publication of rationale documents.
    • These efforts support appropriate antimicrobial use and combat resistance.